Strs Ohio Acquires Shares of 11,300 HealthEquity, Inc. $HQY

Key Points

• Strs Ohio has acquired 11,300 shares of HealthEquity, Inc. valued at approximately $999,000, marking a new position in the healthcare services sector.
• The stock price of HealthEquity is currently trading at $95.59, with a market capitalization of $8.24 billion and a notable price-to-earnings ratio of 57.93.
• Equities analysts are optimistic about HealthEquity, with multiple firms raising their price targets, including Bank of America increasing it from $110.00 to $125.00 and maintaining a "buy" rating.

Strs Ohio purchased a new position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 11,300 shares of the company's stock, valued at approximately $999,000.

Other institutional investors have also recently made changes to their positions in the company. Wealth Enhancement Advisory Services LLC raised its stake in shares of HealthEquity by 24.7% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 6,380 shares of the company's stock worth $564,000 after buying an additional 1,265 shares during the period. Mirae Asset Global Investments Co. Ltd. grew its stake in HealthEquity by 7,983.6% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 24,655 shares of the company's stock valued at $2,179,000 after purchasing an additional 24,350 shares during the last quarter. GAMMA Investing LLC boosted its holdings in HealthEquity by 25.9% in the first quarter. GAMMA Investing LLC now owns 1,571 shares of the company's stock worth $139,000 after acquiring an additional 323 shares in the last quarter. Price T Rowe Associates Inc. MD raised its stake in shares of HealthEquity by 995.6% in the first quarter. Price T Rowe Associates Inc. MD now owns 639,345 shares of the company's stock worth $56,500,000 after purchasing an additional 580,988 shares during the last quarter. Finally, WCM Investment Management LLC acquired a new position in HealthEquity in the first quarter valued at approximately $20,230,000. Hedge funds and other institutional investors own 99.55% of the company's stock.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, EVP Michael Henry Fiore sold 1,794 shares of the company's stock in a transaction dated Monday, July 7th. The shares were sold at an average price of $101.73, for a total transaction of $182,503.62. Following the completion of the sale, the executive vice president directly owned 53,225 shares of the company's stock, valued at approximately $5,414,579.25. This represents a 3.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Delano Ladd sold 6,000 shares of the stock in a transaction that occurred on Friday, September 19th. The stock was sold at an average price of $94.11, for a total transaction of $564,660.00. Following the completion of the sale, the executive vice president directly owned 79,456 shares of the company's stock, valued at $7,477,604.16. This trade represents a 7.02% decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.50% of the company's stock.

Analyst Ratings Changes

A number of research firms have weighed in on HQY. JPMorgan Chase & Co. boosted their price objective on HealthEquity from $125.00 to $126.00 and gave the stock an "overweight" rating in a research note on Wednesday, September 3rd. Wall Street Zen raised HealthEquity from a "hold" rating to a "buy" rating in a report on Friday, June 6th. The Goldman Sachs Group upped their price objective on shares of HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 4th. Raymond James Financial reissued a "strong-buy" rating and set a $120.00 price target (up previously from $115.00) on shares of HealthEquity in a research note on Tuesday, July 8th. Finally, Barrington Research reaffirmed an "outperform" rating and set a $125.00 price objective on shares of HealthEquity in a research note on Friday, August 29th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus price target of $119.77.

HealthEquity Stock Performance

HQY stock traded up $2.23 during trading on Monday, reaching $95.97. 859,094 shares of the company's stock were exchanged, compared to its average volume of 1,243,952. HealthEquity, Inc. has a 1-year low of $74.07 and a 1-year high of $116.65. The firm has a market cap of $8.27 billion, a PE ratio of 58.16, a P/E/G ratio of 1.34 and a beta of 0.50. The company's fifty day moving average price is $92.82 and its 200-day moving average price is $93.91. The company has a quick ratio of 4.23, a current ratio of 4.23 and a debt-to-equity ratio of 0.47.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.